Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

参天製薬

SATO PHARMACEUTICAL

C.Uyemura

日油

ZERIA PHARMACEUTICAL

kyowa Hakko Kirin

日本曹達

Eisai

KOSE

POLA ORBIS HOLDINGS

Chugoku Marine Paints

FUJIKURA KASEI

KAKEN PHARMACEUTICAL

DAINICHISEIKA COLOR & CHEMICALS MFG.

Sumitomo Bakelite

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: JSP (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: JSP (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	1.41% (-12.05%)	3.93% (-0.50%)	5.30% (1.53%)	3.31% (-1.67%)	3.46% (3.05%)
C/F margin (Industry Average)	6.34% (-3.31%)	13.82% (8.51%)	8.52% (7.04%)	5.92% (6.35%)	7.83% (8.25%)
ROA (Industry Average)	1.62% (0.52%)	3.72% (1.04%)	5.47% (2.07%)	3.48% (0.06%)	3.47% (2.71%)
ROE (Industry Average)	3.25% (-1.43%)	6.98% (0.03%)	10.50% (2.96%)	6.54% (4.68%)	6.22% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	9.31% (5.01%)	1.23% (2.61%)	1.89% (-0.40%)	12.81% (8.16%)
Sales growth (Industry Average)	- (-)	-15.47% (-2.67%)	12.71% (5.36%)	1.55% (1.07%)	2.82% (2.24%)
Net profit growth (Industry Average)	- (-)	134.91% (203.46%)	52.10% (63.25%)	-36.48% (3.89%)	7.22% (90.38%)
Operating C/F growth (Industry Average)	- (-)	84.09% (275.10%)	-30.51% (35.09%)	-29.43% (-6.09%)	35.97% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	49.81% (53.80%)	53.26% (54.51%)	52.13% (55.00%)	53.17% (53.59%)	55.91% (56.30%)
Liquidity ratio (Industry Average)	149.53% (217.72%)	164.89% (225.70%)	160.11% (237.55%)	166.53% (239.89%)	169.22% (236.21%)
C/F ratio current liabilities (Industry Average)	478.36% (777.21%)	252.54% (303.31%)	406.98% (434.79%)	543.52% (929.73%)	415.46% (573.30%)
Quick ratio (Industry Average)	110.34% (138.97%)	129.18% (148.85%)	125.93% (156.17%)	127.76% (160.84%)	128.23% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	88.54day (83.89day)	111.51day (94.27day)	105.99day (93.96day)	113.54day (97.92day)	109.53day (98.27day)
Inventory turnover (Industry Average)	34.21day (54.45day)	35.05day (52.58day)	33.05day (52.64day)	37.10day (56.59day)	39.26day (58.68day)
Payable turnover (Industry Average)	34.28day (45.01day)	42.19day (49.82day)	40.75day (49.52day)	46.72day (52.10day)	40.35day (51.12day)
Working capita turnover (Industry Average)	88.47day (93.32day)	104.37day (97.02day)	98.29day (97.08day)	103.93day (102.41day)	108.44day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	107.80% (34.57%)	37.05% (1.49%)	-19.54% (-3.85%)	12.95% (21.16%)
Dividend Yield (Industry Average)	3.39% (3.20%)	1.31% (1.93%)	1.95% (2.17%)	2.71% (2.45%)	2.37% (2.07%)
PER (Industry Average)	12.39% (25.22%)	10.96% (23.06%)	9.87% (16.22%)	12.51% (29.19%)	13.18% (16.58%)
PBR (Industry Average)	0.40% (0.86%)	0.76% (1.06%)	1.03% (1.04%)	0.81% (0.95%)	0.82% (1.08%)
PCFR (Industry Average)	2.76% (7.18%)	3.11% (9.23%)	6.15% (-2.43%)	7.01% (9.50%)	5.82% (7.56%)
PSR (Industry Average)	0.17% (0.77%)	0.43% (0.88%)	0.52% (1.10%)	0.41% (0.90%)	0.45% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	0.46% (-27.66%)	3.09% (-4.34%)	5.82% (-5.37%)	4.04% (-10.69%)	3.69% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	0.40% (0.52%)	2.42% (0.92%)	4.71% (1.42%)	3.16% (-0.27%)	2.88% (1.53%)
ROE (Industry Average)	0.80% (-0.84%)	4.61% (-0.46%)	9.22% (1.81%)	6.02% (3.42%)	5.42% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	3.53% (3.64%)	3.32% (3.03%)	4.06% (0.04%)	2.98% (3.91%)
Sales growth (Industry Average)	- (-)	-9.45% (-3.48%)	9.65% (6.70%)	-2.08% (0.75%)	1.49% (-1.74%)
Net profit growth (Industry Average)	- (-)	495.83% (166.48%)	106.48% (43.48%)	-32.01% (-47.04%)	-7.33% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	50.48% (56.79%)	52.56% (57.65%)	51.05% (57.17%)	52.56% (55.93%)	53.17% (57.57%)
Liquidity ratio (Industry Average)	132.22% (337.22%)	135.14% (276.75%)	131.42% (266.94%)	138.94% (314.47%)	133.91% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	94.06% (167.28%)	98.81% (183.78%)	101.42% (174.83%)	99.66% (228.06%)	95.51% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	114.45day (87.55day)	133.30day (98.39day)	127.84day (95.88day)	144.70day (98.58day)	137.88day (67.18day)
Inventory turnover (Industry Average)	32.42day (50.17day)	32.92day (48.43day)	29.79day (47.43day)	35.76day (50.67day)	36.73day (38.21day)
Payable turnover (Industry Average)	40.92day (45.70day)	49.06day (51.63day)	45.62day (51.13day)	57.50day (53.57day)	51.85day (34.24day)
Working capita turnover (Industry Average)	105.96day (92.02day)	117.16day (95.19day)	112.01day (92.19day)	122.96day (95.69day)	122.76day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	107.80% (34.46%)	37.05% (3.11%)	-19.54% (-3.30%)	12.95% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	64.13% (34.12%)	22.36% (27.80%)	14.84% (13.58%)	17.57% (22.26%)	21.41% (26.42%)
PBR (Industry Average)	0.51% (0.97%)	1.03% (1.21%)	1.36% (1.17%)	1.05% (1.08%)	1.16% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.30% (3.42%)	0.69% (4.34%)	0.86% (3.67%)	0.71% (4.37%)	0.79% (10.14%)

Financial Indicator Details: JSP

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	1.41%	3.93%	5.30%	3.31%	3.46%
C/F margin	6.34%	13.82%	8.52%	5.92%	7.83%
ROA	1.62%	3.72%	5.47%	3.48%	3.47%
ROE	3.25%	6.98%	10.50%	6.54%	6.22%
Recurring margin	2.87%	6.78%	8.56%	5.92%	5.13%
EBIT margin	2.87%	6.41%	8.19%	5.53%	4.93%
EBITDA margin	8.12%	12.15%	13.18%	10.46%	9.51%
NOPAT margin	1.72%	3.84%	4.91%	3.32%	2.96%
Sales SG rates	75.88%	69.70%	69.93%	72.28%	73.54%
Sales SG&A rates	21.31%	23.32%	21.85%	22.04%	21.69%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	5.25%	5.74%	4.98%	4.93%	4.57%
Capital expenditures net sales ratio	-4.52%	-3.92%	-3.66%	-6.43%	-6.47%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	32.98%	13.39%	-30.51%	20.20%
Equity growth	-	9.31%	1.23%	1.89%	12.81%
Total assets growth	-	2.23%	3.42%	-0.08%	7.28%
Sales growth	-	-15.47%	12.71%	1.55%	2.82%
Net profit growth	-	134.91%	52.10%	-36.48%	7.22%
Operating C/F growth	-	84.09%	-30.51%	-29.43%	35.97%
Recurring profit growth	-	99.42%	42.12%	-29.69%	-11.00%
EBIT growth	-	88.30%	44.14%	-31.41%	-8.25%
EBITDA growth	-	26.40%	22.20%	-19.33%	-6.58%
NOPAT growth	-	88.30%	44.14%	-31.41%	-8.25%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	49.81%	53.26%	52.13%	53.17%	55.91%
Liquidity ratio	149.53%	164.89%	160.11%	166.53%	169.22%
C/F ratio current liabilities	478.36%	252.54%	406.98%	543.52%	415.46%
Quick ratio	110.34%	129.18%	125.93%	127.76%	128.23%
Fixed ratio	86.77%	76.22%	73.56%	74.21%	72.01%
D/E ratio	60.45%	46.24%	49.56%	43.19%	38.22%
Loan to Value Ratio	30.11%	24.62%	25.84%	22.96%	21.37%
Business investment C/F ratio	-71.31%	-28.38%	-42.95%	-108.56%	-82.62%
Liabilities with interest growth	-	-16.38%	8.52%	-11.21%	-0.15%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	33.78day	53.15day	53.47day	36.58day	42.77day
Receivables turnover	88.54day	111.51day	105.99day	113.54day	109.53day
Inventory turnover	34.21day	35.05day	33.05day	37.10day	39.26day
Fixed assets turnover	137.80day	156.53day	135.70day	137.36day	146.24day
Total asset turnover	318.80day	385.57day	353.81day	348.09day	363.20day
Payable turnover	34.28day	42.19day	40.75day	46.72day	40.35day
Capital turnover	38.29day	45.30day	40.19day	39.58day	38.49day
Equity turnover	158.80day	205.37day	184.46day	185.09day	203.06day
Working capita turnover	88.47day	104.37day	98.29day	103.93day	108.44day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 8 B	¥ 11 B	¥ 13 B	¥ 9 B	¥ 11 B
Accounts receivable-trade	¥ 23 B	¥ 24 B	¥ 26 B	¥ 29 B	¥ 28 B
Other Current Assets	¥ 34 B	¥ 35 B	¥ 37 B	¥ 40 B	¥ 41 B
Current Assets	¥ 43 B	¥ 46 B	¥ 51 B	¥ 50 B	¥ 52 B
Tangible Assets	¥ 36 B	¥ 34 B	¥ 34 B	¥ 35 B	¥ 38 B
Intangible Assets	¥ 715 M	¥ 936 M	¥ 986 M	¥ 967 M	¥ 1 B
Investment etc.	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 3 B
Total Assets	¥ 84 B	¥ 86 B	¥ 89 B	¥ 89 B	¥ 95 B
Current Liabilities	¥ 29 B	¥ 28 B	¥ 31 B	¥ 30 B	¥ 31 B
Fixed Liabilities	¥ 12 B	¥ 11 B	¥ 10 B	¥ 11 B	¥ 10 B
Liabilities with interest	¥ 25 B	¥ 21 B	¥ 23 B	¥ 20 B	¥ 20 B
Net Assets	¥ 42 B	¥ 45 B	¥ 46 B	¥ 47 B	¥ 53 B
Capital stock	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B
Capital surplus etc.	¥ 31 B	¥ 35 B	¥ 36 B	¥ 37 B	¥ 43 B
Liabilities and net assets	¥ 84 B	¥ 86 B	¥ 89 B	¥ 89 B	¥ 95 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 96 B	¥ 81 B	¥ 91 B	¥ 93 B	¥ 96 B
Cost of Sales	¥ 73 B	¥ 56 B	¥ 64 B	¥ 67 B	¥ 70 B
Gross profit	¥ 23 B	¥ 24 B	¥ 27 B	¥ 25 B	¥ 25 B
Other income	¥ 969 M	¥ 726 M	¥ 1 B	¥ 1 B	¥ 842 M
SG&A	¥ 20 B	¥ 19 B	¥ 20 B	¥ 20 B	¥ 20 B
Other expenses	¥ 1 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 1 B
Net income	¥ 1 B	¥ 3 B	¥ 4 B	¥ 3 B	¥ 3 B
Operating income	¥ 2 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 4 B
Ordinary Income	¥ 2 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 4 B
EBITDA	¥ 7 B	¥ 9 B	¥ 12 B	¥ 9 B	¥ 9 B
Income before income taxes	¥ 2 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 4 B
Depreciation	¥ 5 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 839 M	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 6 B	¥ 11 B	¥ 7 B	¥ 5 B	¥ 7 B
Investment CF	¥ -4 B	¥ -4 B	¥ -5 B	¥ -6 B	¥ -5 B
Financial CF	¥ 298 M	¥ -4 B	¥ -475 M	¥ -3 B	¥ -1 B
Foreign Exchange Effects	¥ -878 M	¥ 44 M	¥ -748 M	¥ -303 M	¥ 460 M
Net Change in Cash	¥ 567 M	¥ 2 B	¥ 1 B	¥ -4 B	¥ 1 B
Free CF	¥ 1 B	¥ 7 B	¥ 2 B	¥ -606 M	¥ 1 B
Capital expenditures	¥ -4 B	¥ -3 B	¥ -3 B	¥ -6 B	¥ -6 B
Cash dividends paid	¥ -574 M	¥ -464 M	¥ -941 M	¥ -1 B	¥ -1 B
Repayment loans	¥ -4 B	¥ -4 B	¥ -4 B	¥ -5 B	¥ -5 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	¥ 31 M	-	-	-	-
Dividends from surplus	¥ -469 M	¥ -434 M	¥ -819 M	¥ -894 M	¥ -894 M
Net income	¥ 1 B	¥ 3 B	¥ 4 B	¥ 3 B	¥ 3 B
Purchase of treasury stock	¥ -168 M	¥ -1 M	¥ -1 B	-	-
Other Change in Stockholders Equity	¥ -472 M	¥ 90 M	¥ -2 M	¥ -1 M	¥ -1 M
Other Change in Net Assets	¥ -6 B	¥ 1 B	¥ -2 B	¥ -1 B	¥ 3 B
Net Change in Net Assets	¥ -6 B	¥ 3 B	¥ 569 M	¥ 881 M	¥ 6 B

Financial Indicator Details: JSP

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	0.46%	3.09%	5.82%	4.04%	3.69%
C/F margin	-	-	-	-	-
ROA	0.40%	2.42%	4.71%	3.16%	2.88%
ROE	0.80%	4.61%	9.22%	6.02%	5.42%
Recurring margin	1.47%	6.22%	8.44%	5.63%	4.82%
EBIT margin	1.51%	5.41%	8.36%	5.82%	4.70%
EBITDA margin	2.23%	6.29%	9.24%	6.70%	5.60%
NOPAT margin	0.90%	3.25%	5.01%	3.49%	2.82%
Sales SG rates	78.39%	71.22%	71.63%	73.35%	74.91%
Sales SG&A rates	21.07%	23.39%	22.69%	23.40%	23.30%
Sales R&D expenses rates	3.03%	3.17%	2.88%	3.17%	3.27%
Sales depreciation rates	0.72%	0.87%	0.87%	0.87%	0.89%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-5.20%	128.60%	-72.42%	44.31%
Equity growth	-	3.53%	3.32%	4.06%	2.98%
Total assets growth	-	-0.56%	6.36%	1.09%	1.79%
Sales growth	-	-9.45%	9.65%	-2.08%	1.49%
Net profit growth	-	495.83%	106.48%	-32.01%	-7.33%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	283.19%	48.59%	-34.67%	-13.10%
EBIT growth	-	224.61%	69.26%	-31.76%	-17.97%
EBITDA growth	-	154.53%	60.99%	-28.94%	-15.20%
NOPAT growth	-	224.61%	69.26%	-31.76%	-17.97%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	50.48%	52.56%	51.05%	52.56%	53.17%
Liquidity ratio	132.22%	135.14%	131.42%	138.94%	133.91%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	94.06%	98.81%	101.42%	99.66%	95.51%
Fixed ratio	68.79%	64.05%	60.35%	58.90%	59.16%
D/E ratio	67.06%	54.58%	60.73%	52.94%	50.93%
Loan to Value Ratio	33.85%	28.69%	31.01%	27.82%	27.08%
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-15.74%	14.97%	-9.28%	-0.91%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	16.33day	17.10day	35.65day	10.04day	14.27day
Receivables turnover	114.45day	133.30day	127.84day	144.70day	137.88day
Inventory turnover	32.42day	32.92day	29.79day	35.76day	36.73day
Fixed assets turnover	147.05day	156.56day	139.00day	144.20day	146.95day
Total asset turnover	423.41day	465.01day	451.09day	465.71day	467.08day
Payable turnover	40.92day	49.06day	45.62day	57.50day	51.85day
Capital turnover	65.79day	72.66day	66.26day	67.67day	66.67day
Equity turnover	213.75day	244.42day	230.32day	244.78day	248.38day
Working capita turnover	105.96day	117.16day	112.01day	122.96day	122.76day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 2 B	¥ 2 B	¥ 5 B	¥ 1 B	¥ 2 B
Accounts receivable-trade	¥ 17 B	¥ 18 B	¥ 19 B	¥ 21 B	¥ 20 B
Other Current Assets	¥ 25 B	¥ 26 B	¥ 26 B	¥ 30 B	¥ 30 B
Current Assets	¥ 28 B	¥ 28 B	¥ 32 B	¥ 32 B	¥ 32 B
Tangible Assets	¥ 22 B	¥ 21 B	¥ 21 B	¥ 21 B	¥ 22 B
Intangible Assets	¥ 577 M	¥ 748 M	¥ 584 M	¥ 455 M	¥ 274 M
Investment etc.	¥ 13 B	¥ 13 B	¥ 14 B	¥ 15 B	¥ 15 B
Total Assets	¥ 65 B	¥ 64 B	¥ 68 B	¥ 69 B	¥ 70 B
Current Liabilities	¥ 21 B	¥ 21 B	¥ 24 B	¥ 23 B	¥ 24 B
Fixed Liabilities	¥ 10 B	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B
Liabilities with interest	¥ 22 B	¥ 18 B	¥ 21 B	¥ 19 B	¥ 19 B
Net Assets	¥ 32 B	¥ 34 B	¥ 35 B	¥ 36 B	¥ 37 B
Capital stock	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B
Capital surplus etc.	¥ 22 B	¥ 23 B	¥ 25 B	¥ 26 B	¥ 27 B
Liabilities and net assets	¥ 65 B	¥ 64 B	¥ 68 B	¥ 69 B	¥ 70 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 56 B	¥ 50 B	¥ 55 B	¥ 54 B	¥ 55 B
Cost of Sales	¥ 44 B	¥ 36 B	¥ 39 B	¥ 40 B	¥ 41 B
Gross profit	¥ 12 B	¥ 14 B	¥ 15 B	¥ 14 B	¥ 13 B
Other income	¥ 971 M	¥ 778 M	¥ 2 B	¥ 1 B	¥ 1 B
SG&A	¥ 11 B	¥ 11 B	¥ 12 B	¥ 12 B	¥ 12 B
Other expenses	¥ 1 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 890 M
Net income	¥ 264 M	¥ 1 B	¥ 3 B	¥ 2 B	¥ 2 B
Operating income	¥ 297 M	¥ 2 B	¥ 3 B	¥ 1 B	¥ 984 M
Ordinary Income	¥ 827 M	¥ 3 B	¥ 4 B	¥ 3 B	¥ 2 B
EBITDA	¥ 1 B	¥ 3 B	¥ 5 B	¥ 3 B	¥ 3 B
Income before income taxes	¥ 596 M	¥ 2 B	¥ 4 B	¥ 2 B	¥ 2 B
Depreciation	¥ 409 M	¥ 446 M	¥ 490 M	¥ 480 M	¥ 495 M
R&D expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Income taxes	¥ 332 M	¥ 949 M	¥ 1 B	¥ 776 M	¥ 399 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	¥ 31 M	-	-	-	-
Dividends from surplus	¥ -469 M	¥ -434 M	¥ -819 M	¥ -894 M	¥ -894 M
Net income	¥ 264 M	¥ 1 B	¥ 3 B	¥ 2 B	¥ 2 B
Purchase of treasury stock	¥ -168 M	¥ -1 M	¥ -1 B	-	-
Other Change in Stockholders Equity	-	¥ -1 M	¥ -2 M	¥ -1 M	¥ -2 M
Other Change in Net Assets	¥ 32 M	¥ 25 M	¥ -136 M	¥ 118 M	¥ -56 M
Net Change in Net Assets	¥ -310 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: JSP (Annual )

Statement Type

Annual : JSP

First quarter : JSP

Second quarter : JSP

Third quarter : JSP

Analysis Menu

Outline : JSP

Statement : JSP

Rating : JSP

Indicator : JSP

Download : JSP

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo千代田区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
JSP	7942	TSE 1st	Chemicals	3	Annual	A

Related Company

Sumitomo Bakelite (Sales ¥ 183 B)

KOSE (Sales ¥ 170 B)

SANKO GOSEI (Sales ¥ 43 B)

和光純薬工業 (Sales ¥ 74 B)

ZERIA PHARMACEUTICAL (Sales ¥ 53 B)

JSP (Sales ¥ 96 B)

Central Glass (Sales ¥ 173 B)

日本新薬 (Sales ¥ 69 B)

DAINICHISEIKA COLOR & CHEMICALS MFG. (Sales ¥ 151 B)

SATO PHARMACEUTICAL (Sales ¥ 38 B)

Milbon (Sales ¥ 23 B)

参天製薬 (Sales ¥ 119 B)

MATSUMOTO YUSHI-SEIYAKU (Sales ¥ 27 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .